Tag: TAE
Hydrogel embolic system demonstrates positive safety and efficacy in “first” peripheral...
Preliminary results from the prospective, randomised, multicentre Instylla Hydrogel Embolic System (HES; Instylla) trial show the liquid embolic met primary safety and effectiveness endpoints,...
CIREL study finds comparable overall survival between indication for irinotecan-TACE in...
Results from CIREL—the largest, pan-European, prospective study of irinotecan-eluting transarterial chemoembolization (TACE) for colorectal liver metastases (CRLMs), show a comparably long median overall survival...
First release RETNET data show no difference in progression-free survival between...
New data from a prospective, multicentre randomised controlled trial show similar hepatic progression-free survival (hPFS) using bland transarterial embolization (TAE) or transarterial chemoembolization (TACE)...
Vast majority of patients prefer radial access for embolization therapies in...
“While both radial and femoral accesses are safe and effective for transarterial liver embolization, it is clear that the patients prefer radial access,” said Marcelo Guimaraes, Charleston, USA, who was presenting on the...
